Barriers to Completion of the Hepatitis C Cascade of Care in Rhode Islandtext_resourcesThis retrospective cohort study will examine trends in HCV treatment within the Lifespan system via a data set of 1,040 patients. The goal of the project is to identify demographic, health, and social factors that may be aiding or impeding completion of the HCV cascade of care, a standard treatment protocol which includes antibody testing, RNA testing, liver function testing, and treatment with direct-acting antivirals (DAAs), with the eventual goal of achieving sustained virologic response (SVR), which indicates that the infection has been cleared. In doing so, we hope to contribute to ongoing efforts to improve the accessibility of Hepatitis C treatment for vulnerable patient populations in Rhode Island and to support future research and quality improvement projects.Rosenberg, Mark BAAuthorHarvey, Leah MD MPHAuthorBrown University. Alpert Medical School. Scholarly Concentration Program. Non-Scholarly Concentratorresearch programHepatitis CHepatitis C virusEnglish2024Non-Scholarly ConcentratorAll rights reservedIn CopyrightAll Rights Reserved